Stock RTSL RAPID THERAPEUTIC SCIENCE LABORATORIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Rapid Therapeutic Science Laboratories, Inc.

Equities

RTSL

US7534312043

Market Closed - OTC Markets
Other stock markets
 17:04:13 18/06/2024 BST 		5-day change 1st Jan Change
0.0012 USD -.--% Intraday chart for Rapid Therapeutic Science Laboratories, Inc. -.--% -70.73%
2023 Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
2023 Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Rapid Therapeutics Science Laboratories Announces Launch of its New Facility Located in Addison, Tex
CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
Rapid Therapeutic Finalizes Lab Work on Pharmaceutical Formulas
CI
Rapid Therapeutic Prepares to File Investigational New Drug Application for its CBD Metered Dose Inhaler with FDA
CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Nine Months Ended December 31, 2020
CI
Empower : Holley to Go Public in Merger With Bank-Check Company Empower
MT
Rapid Therapeutic Science Laboratories, Inc. completed the acquisition of All of the Assets of Razor Jacket, LLC for $14 million.
CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Second Quarter Ended September 30, 2020
CI
Rapid Therapeutic Enters Letter of Intent to Expand Production Capability to 3,000,000 MDI and $100,000,000 in Revenue Annually
CI
Rapid Therapeutic Science Laboratories, Inc. signed a letter of intent to acquire all of the Assets of Razor Jacket, LLC.
CI
Rapid Therapeutic Science Laboratories, Inc. Announces Completion of New ISO 13485 Laboratory
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RTSL Stock
  4. News Rapid Therapeutic Science Laboratories, Inc.
  5. Highlights